| Melanoma D Schadendorf, ACJ Van Akkooi, C Berking, KG Griewank, R Gutzmer, ... The Lancet 392 (10151), 971-984, 2018 | 1268 | 2018 |
| The genetic landscape of clinical resistance to RAF inhibition in metastatic melanoma EM Van Allen, N Wagle, A Sucker, DJ Treacy, CM Johannessen, ... Cancer discovery 4 (1), 94-109, 2014 | 961 | 2014 |
| Cutaneous, gastrointestinal, hepatic, endocrine, and renal side-effects of anti-PD-1 therapy L Hofmann, A Forschner, C Loquai, SM Goldinger, L Zimmer, S Ugurel, ... European journal of cancer 60, 190-209, 2016 | 672 | 2016 |
| Metastatic potential of melanomas defined by specific gene expression profiles with no BRAF signature KS Hoek, NC Schlegel, P Brafford, A Sucker, S Ugurel, R Kumar, ... Pigment cell research 19 (4), 290-302, 2006 | 603 | 2006 |
| Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III … D Schadendorf, S Ugurel, B Schuler-Thurner, FO Nestle, A Enk, ... Annals of Oncology 17 (4), 563-570, 2006 | 602 | 2006 |
| Neurological, respiratory, musculoskeletal, cardiac and ocular side-effects of anti-PD-1 therapy L Zimmer, SM Goldinger, L Hofmann, C Loquai, S Ugurel, I Thomas, ... European journal of cancer 60, 210-225, 2016 | 577 | 2016 |
| Increased serum concentration of angiogenic factors in malignant melanoma patients correlates with tumor progression and survival S Ugurel, G Rappl, W Tilgen, U Reinhold Journal of clinical oncology 19 (2), 577-583, 2001 | 485 | 2001 |
| Deep learning outperformed 136 of 157 dermatologists in a head-to-head dermoscopic melanoma image classification task TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ... European Journal of Cancer 113, 47-54, 2019 | 441 | 2019 |
| Lymphatic endothelium‐specific hyaluronan receptor LYVE‐1 is expressed by stabilin‐1+, F4/80+, CD11b+ macrophages in malignant tumours and wound healing tissue in vivo and in … K Schledzewski, M Falkowski, G Moldenhauer, P Metharom, ... The Journal of Pathology: A Journal of the Pathological Society of Great …, 2006 | 324 | 2006 |
| Survival of patients with advanced metastatic melanoma: the impact of novel therapies–update 2017 S Ugurel, J Röhmel, PA Ascierto, KT Flaherty, JJ Grob, A Hauschild, ... European Journal of Cancer 83, 247-257, 2017 | 297 | 2017 |
| Lack of clinical efficacy of imatinib in metastatic melanoma S Ugurel, R Hildenbrand, A Zimpfer, P La Rosee, P Paschka, A Sucker, ... British journal of cancer 92 (8), 1398-1405, 2005 | 291 | 2005 |
| Superior skin cancer classification by the combination of human and artificial intelligence A Hekler, JS Utikal, AH Enk, A Hauschild, M Weichenthal, RC Maron, ... European Journal of Cancer 120, 114-121, 2019 | 289 | 2019 |
| A convolutional neural network trained with dermoscopic images performed on par with 145 dermatologists in a clinical melanoma image classification task TJ Brinker, A Hekler, AH Enk, J Klode, A Hauschild, C Berking, B Schilling, ... European Journal of Cancer 111, 148-154, 2019 | 253 | 2019 |
| Final results of phase III SYMMETRY study: randomized, double-blind trial of elesclomol plus paclitaxel versus paclitaxel alone as treatment for chemotherapy-naive patients … SJ O'Day, AMM Eggermont, V Chiarion-Sileni, R Kefford, JJ Grob, ... Journal of Clinical Oncology 31 (9), 1211-1218, 2013 | 219 | 2013 |
| Differential clinical significance of individual NKG2D ligands in melanoma: soluble ULBP2 as an indicator of poor prognosis superior to S100B A Paschen, A Sucker, B Hill, I Moll, M Zapatka, XD Nguyen, GC Sim, ... Clinical cancer research 15 (16), 5208-5215, 2009 | 211 | 2009 |
| Soluble human leukocyte antigen–G serum level is elevated in melanoma patients and is further increased by interferon‐α immunotherapy S Ugurel, V Rebmann, S Ferrone, W Tilgen, H Grosse‐Wilde, U Reinhold Cancer: Interdisciplinary International Journal of the American Cancer …, 2001 | 200 | 2001 |
| Systematic outperformance of 112 dermatologists in multiclass skin cancer image classification by convolutional neural networks RC Maron, M Weichenthal, JS Utikal, A Hekler, C Berking, A Hauschild, ... European Journal of Cancer 119, 57-65, 2019 | 196 | 2019 |
| Programmed cell death protein-1 (PD-1) inhibitor therapy in patients with advanced melanoma and preexisting autoimmunity or ipilimumab-triggered autoimmunity R Gutzmer, A Koop, F Meier, JC Hassel, P Terheyden, L Zimmer, ... European Journal of Cancer 75, 24-32, 2017 | 189 | 2017 |
| Survival of patients with advanced metastatic melanoma: the impact of novel therapies S Ugurel, J Röhmel, PA Ascierto, KT Flaherty, JJ Grob, A Hauschild, ... European journal of cancer 53, 125-134, 2016 | 179 | 2016 |
| Effect of common B-RAF and N-RAS mutations on global gene expression in melanoma cell lines S Bloethner, B Chen, K Hemminki, J Müller-Berghaus, S Ugurel, ... Carcinogenesis 26 (7), 1224-1232, 2005 | 175 | 2005 |
